Add to Basket Bulk discount
Order hotline:
+1 404 474 4654
+1 888 205 9894 (TF)

Aspartyl-tRNA Synthetase 2, Mitochondrial (DARS2) (C-Term) antibody

Antigen

Aspartyl-tRNA Synthetase 2, Mitochondrial (DARS2)

Synonyms LBSL, ASPRS, FLJ10514, MT-ASPRS, RP3-383J4.2, MGC157196, si:dkey-21n10.1, DKFZp469I0720
Binding Site
Alternatives

C-Term

Clonality Polyclonal
Host
Alternatives

Rabbit

Reactivity
Alternatives

Human

Application
Alternatives Western Blotting (WB), Immunohistochemistry (IHC), ELISA
2 references available
Certificates ISO 9001:2008
Catalog no. ABIN392298
Quantity 0.1 mg  (0.25 mg/ml)
Price 280.50 $   Plus shipping costs $45.00
Bulk discount
Shipping to
Availability Will be delivered in 2 to 3 Business Days

Additional Information

Alternative name DARS2
Gene ID 55157
UniProt Q6PI48
Immunogen This DARS2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 616~645 amino acids from the C-terminal region of human DARS2.
Isotype Ig
Description Other names: Aspartyl-tRNA synthetase, mitochondrial [Precursor], EC 6.1.1.12, Aspartate--tRNA ligase, AspRS, DARS2
Characteristics Purified Rabbit Polyclonal Antibody (Pab)
Specificity This DARS2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 616~645 amino acids from the C-terminal region of human DARS2.
Molecular Weight 73563 DA
Comments

Background: Aspartyl-tRNA synthetase (DARS) is part of a multienzyme complex of aminoacyl-tRNA synthetases. Aspartyl-tRNA synthetase charges its cognate tRNA with aspartate during protein biosynthesis. Defects in DARS2 are a cause of leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) [MIM:611105]. LBSL is an autosomal recessive disease and is defined on the basis of a highly characteristic constellation of abnormalities observed by magnetic resonance imaging and spectroscopy. Affected individuals develop slowly progressive cerebellar ataxia, spasticity, and dorsal column dysfunction, sometimes with a mild cognitive deficit or decline.

Application Details

Application Notes The suggested dilution is: ELISA ~~ 1:1,000 Western blotting~~ 1:50~100 Immunohistochemistry ~~ 1:10~50
Concentration 0.25 mg/ml
Purification Purified
Buffer Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
Storage Maintain refrigerated at 2-8 deg C for up to 6 months. For long term storage store at -20 deg C in small aliquots to prevent freeze-thaw cycles
Research Area Translation Factors, Signaling, Cell Structure
Restrictions For Research Use only

Publications

Product Bonnefond, Fender, Rudinger-Thirion et al.: "Toward the full set of human mitochondrial aminoacyl-tRNA synthetases: characterization of AspRS and TyrRS." in: Biochemistry, Vol. 44, Issue 12, pp. 4805-16, 2005 (PubMed).

Scheper, van der Klok, van Andel et al.: "Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation." in: Nature genetics, Vol. 39, Issue 4, pp. 534-9, 2007 (PubMed).

Alternatives

Alternatives for antigen "Aspartyl-tRNA Synthetase 2, Mitochondrial (DARS2)", type "Antibodies"
Hosts Rabbit (6)
Reactivities Human (6), Mouse (Murine) (3), Rat (Rattus) (3), Cat (Feline) (1), Chicken (1), Cow (Bovine) (1), Dog (Canine) (1)
Applications Western Blotting (WB) (6), ELISA (5), Immunohistochemistry (IHC) (4), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)) (2), Immunofluorescence (IF) (1), Immunoprecipitation (IP) (1)
Epitopes C-Term (2), Center (1)